Literature DB >> 18021268

Widespread idiopathic pyoderma gangrenosum evolved from ulcerative to vegetative type: a 10-year history with a recent response to infliximab.

A V Marzano1, A Tourlaki, E Alessi, R Caputo.   

Abstract

Pyoderma gangrenosum (PG) is an infrequent neutrophilic dermatosis, which commonly presents with a limited number of ulcerative, pustular, bullous or vegetative lesions associated with an underlying systemic disorder. We report a 34-year-old man with ulcerative PG that was exceptionally widespread and not associated with any other condition. Moreover, it was resistant to steroid treatment and, after prolonged use of ciclosporin, it unexpectedly developed a vegetative pattern, further supporting the hypothesis that the different forms of PG are part of a single clinical spectrum. Finally, dramatic improvement of the condition occurred after treatment with infliximab, an antitumour necrosis factor-alpha monoclonal antibody; however, this produced circulating autoantibodies. Although this has not had any clinical consequence to date, accurate follow-up in patients treated with infliximab is essential to monitor the onset of a possible autoimmune disorder induced by the drug.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18021268     DOI: 10.1111/j.1365-2230.2007.02607.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  8 in total

1.  Development of pyoderma gangrenosum during therapy with infliximab.

Authors:  Natalia Jaimes-López; Verónica Molina; Juan E Arroyave; Luz A Vasquez; Ana C Ruiz; Rodrigo Castaño; Mario H Ruiz
Journal:  J Dermatol Case Rep       Date:  2009-08-24

2.  Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet's syndrome.

Authors:  A V Marzano; D Fanoni; E Antiga; P Quaglino; M Caproni; C Crosti; P L Meroni; M Cugno
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

Review 3.  A Comprehensive Review of Neutrophilic Diseases.

Authors:  Angelo V Marzano; Alessandro Borghi; Daniel Wallach; Massimo Cugno
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

4.  Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases.

Authors:  A V Marzano; M Cugno; V Trevisan; D Fanoni; L Venegoni; E Berti; C Crosti
Journal:  Clin Exp Immunol       Date:  2010-08-19       Impact factor: 4.330

5.  Pyoderma gangrenosum and tumour necrosis factor alpha inhibitors: A semi-systematic review.

Authors:  Hakim Ben Abdallah; Karsten Fogh; Rikke Bech
Journal:  Int Wound J       Date:  2019-01-03       Impact factor: 3.315

Review 6.  Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet's syndrome: a comprehensive review and disease classification criteria.

Authors:  Angelo V Marzano; Rim S Ishak; Simone Saibeni; Carlo Crosti; Pier Luigi Meroni; Massimo Cugno
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

7.  Postoperative pyoderma gangrenosum in association with renal cell carcinoma and chronic lymphocytic leukemia.

Authors:  Caius Solovan; Robert Smiszek; Claudia Wickenhauser; Elena Chiticariu
Journal:  Infect Dis Ther       Date:  2013-06-11

Review 8.  Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments.

Authors:  Carlo Alberto Maronese; Matthew A Pimentel; May M Li; Alex G Ortega-Loayza; Angelo Valerio Marzano; Giovanni Genovese
Journal:  Am J Clin Dermatol       Date:  2022-05-24       Impact factor: 6.233

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.